{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T15:32:32Z","timestamp":1748964752831,"version":"3.33.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","msard-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.msard.2024.105533","type":"journal-article","created":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T09:36:24Z","timestamp":1709890584000},"page":"105533","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Lymphocytic infiltration in multiple sclerosis"],"prefix":"10.1016","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5525-8442","authenticated-orcid":false,"given":"Ranjeet Singh","family":"Mahla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2024.105533_bib0001","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3389\/fimmu.2017.00753","article-title":"Th1 and Th17 Cells and Associated Cytokines Discriminate among Clinically Isolated Syndrome and Multiple Sclerosis Phenotypes","volume":"8","author":"Arellano","year":"2017","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.msard.2024.105533_bib0002","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s41582-022-00735-5","article-title":"Social determinants of health in multiple sclerosis","volume":"18","author":"Dobson","year":"2022","journal-title":"Nat. Rev. Neurol."},{"issue":"22","key":"10.1016\/j.msard.2024.105533_bib0003","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92724","article-title":"Clonal relationships of CSF B cells in treatment-naive multiple sclerosis patients","volume":"2","author":"Eggers","year":"2017","journal-title":"JCI. Insight."},{"issue":"6","key":"10.1016\/j.msard.2024.105533_bib0004","article-title":"Longitudinally persistent cerebrospinal fluid B cells can resist treatment in multiple sclerosis","volume":"4","author":"Greenfield","year":"2019","journal-title":"JCI. Insight."},{"issue":"7","key":"10.1016\/j.msard.2024.105533_bib0005","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/jamaneurol.2023.1135","article-title":"Population-Based Estimates for the Prevalence of Multiple Sclerosis in the United States by Race, Ethnicity, Age, Sex, and Geographic Region","volume":"80","author":"Hittle","year":"2023","journal-title":"JAMa Neurol."},{"key":"10.1016\/j.msard.2024.105533_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104701","article-title":"B cell depletion therapy does not resolve chronic active multiple sclerosis lesions","volume":"94","author":"Maggi","year":"2023","journal-title":"EBioMedicine"},{"issue":"5","key":"10.1016\/j.msard.2024.105533_bib0007","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1177\/1352458519871818","article-title":"Can CSF biomarkers predict future MS disease activity and severity?","volume":"26","author":"Magliozzi","year":"2020","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2024.105533_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103830","article-title":"Faster B-cell repletion after anti-CD20 infusion in Black patients compared to white patients with neurologic diseases","volume":"63","author":"Saidenberg","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"8","key":"10.1016\/j.msard.2024.105533_bib0009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182462","article-title":"Cerebrospinal fluid B cells and disease progression in multiple sclerosis - A longitudinal prospective study","volume":"12","author":"Wurth","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.msard.2024.105533_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.105047","article-title":"African American patients with Multiple Sclerosis (MS) have higher proportions of CR19+ and CD20+ B-cell lineage cells in their cerebrospinal fluid than White MS patients","author":"Xue","year":"2023","journal-title":"Mult. Scler. Relat. Disord."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824001123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824001123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T11:37:27Z","timestamp":1738064247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034824001123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":10,"alternative-id":["S2211034824001123"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2024.105533","relation":{},"ISSN":["2211-0348"],"issn-type":[{"type":"print","value":"2211-0348"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lymphocytic infiltration in multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2024.105533","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105533"}}